The B Lymphocyte Antigen CD20 pipeline drugs market research report outlays comprehensive information on the B Lymphocyte Antigen CD20 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the B Lymphocyte Antigen CD20 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, Immunology, Central Nervous System, and Genito Urinary System which include the indications Follicular Lymphoma, Diffuse Large B-Cell Lymphoma, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis, Neuromyelitis Optica (Devic’s Syndrome), Kidney Disease (Nephropathy), and Membranous Glomerulonephritis. It also reviews key players involved in B Lymphocyte Antigen CD20 targeted therapeutics development with respective active and dormant or discontinued products.
The B Lymphocyte Antigen CD20 pipeline targets constitutes close to 167 molecules. Out of which, approximately 145 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Filing rejected/ Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/ CTA Filed, Preclinical, and Discovery stages are 5, 2, 18, 25, 33, 4, 7, 33, and 17 respectively. Similarly, the universities portfolio in Phase II, Phase I, Preclinical, and Discovery comprises 10, 8, 3, and 1 molecule.
B Lymphocyte Antigen CD20 overview
B-lymphocyte antigen CD20 is a specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes. Alternative splicing of this gene results in two transcript variants that encode the same protein.
For a complete picture of B Lymphocyte Antigen CD20’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.